UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 18, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 17, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$508.48
Aug 17, 2026
Close before public filing
$508.48
Aug 17, 2026
Return since public filing
-2.24%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000122
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$6.1M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 17, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 17, 2026 | $106.73K |
| United Therapeutics Corp UTHR | Sale | Aug 17, 2026 | $214.43K |
| United Therapeutics Corp UTHR | Sale | Aug 17, 2026 | $60.5K |
| United Therapeutics Corp UTHR | Sale | Aug 17, 2026 | $625.64K |
| United Therapeutics Corp UTHR | Sale | Aug 17, 2026 | $1.28M |
| United Therapeutics Corp UTHR | Sale | Aug 17, 2026 | $1.67M |
| United Therapeutics Corp UTHR | Sale | Aug 17, 2026 | $855.25K |
| United Therapeutics Corp UTHR Current | Exercise | Aug 17, 2026 | $0 |